We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · December 01, 2022

Overall Survival With ctDNA-Guided Therapy in Advanced NSCLC

Nature Medicine

 

Additional Info

Disclosure statements are available on the authors' profiles:

Nature Medicine
Overall survival with circulating tumor DNA-guided therapy in advanced non-small-cell lung cancer
Nat. Med. 2022 Nov 01;28(11)2353-2363, J Jee, ES Lebow, R Yeh, JP Das, A Namakydoust, PK Paik, JE Chaft, G Jayakumaran, A Rose Brannon, R Benayed, A Zehir, M Donoghue, N Schultz, D Chakravarty, R Kundra, R Madupuri, YR Murciano-Goroff, HY Tu, CR Xu, A Martinez, C Wilhelm, J Galle, B Daly, HA Yu, M Offin, MD Hellmann, P Lito, KC Arbour, MG Zauderer, MG Kris, KK Ng, J Eng, I Preeshagul, W Victoria Lai, JJ Fiore, A Iqbal, D Molena, G Rocco, BJ Park, LP Lim, M Li, C Tong-Li, M De Silva, DL Chan, CI Diakos, M Itchins, S Clarke, N Pavlakis, A Lee, N Rekhtman, J Chang, WD Travis, GJ Riely, DB Solit, M Gonen, VW Rusch, A Rimner, D Gomez, A Drilon, HI Scher, SP Shah, MF Berger, ME Arcila, M Ladanyi, RL Levine, R Shen, P Razavi, JS Reis-Filho, DR Jones, CM Rudin, JM Isbell, BT Li

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading